Literature DB >> 8702885

Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization.

S M Santee1, L B Owen-Schaub.   

Abstract

Tumor necrosis factor receptor p75 (TNF-R p75) is a 75-kDa type I transmembrane protein expressed predominantly on cells of hematopoietic lineage. TNF-R p75 belongs to the TNF receptor superfamily characterized by cysteine-rich extracellular regions composed of three to six disulfide-linked domains. In the present report we have characterized, for the first time, the complete gene structure for human TNF-R p75, which spans approximately 43 kbp. The gene consists of 10 exons (ranging from 34 base pairs to 2.5 kilobase pairs) and nine introns (343 base pairs to 19 kilobase pairs). Consensus elements for transcription factors involved in T cell development and activation were noted in the 5'-flanking region including T cell factor-1, Ikaros, AP-1, CK-2, interleukin-6 receptor E (IL-6RE), ISRE, GAS, NF-kappaB, and Sp1. The unusual (GATA)n and (GAA)(GGA) repeats found within intron 1 may prove useful for further genome analysis within the 1p36 chromosomal locus. Characterization of the human TNF-R p75 gene structure will permit further assessment of its involvement in normal hematopoietic cell development and function, autoimmune disease, and nonrandom translocations in hematopoietic malignancies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702885     DOI: 10.1074/jbc.271.35.21151

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene.

Authors:  E J Croager; A M Gout; L J Abraham
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin.

Authors:  K Hahm; B S Cobb; A S McCarty; K E Brown; C A Klug; R Lee; K Akashi; I L Weissman; A G Fisher; S T Smale
Journal:  Genes Dev       Date:  1998-03-15       Impact factor: 11.361

Review 3.  Genetic influences on rheumatoid arthritis in African Americans.

Authors:  Laura B Hughes; Larry W Moreland; S Louis Bridges
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 4.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 5.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

6.  High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells.

Authors:  L Chêne; M T Nugeyre; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 7.  TNF-α signalling and inflammation: interactions between old acquaintances.

Authors:  Hana Zelová; Jan Hošek
Journal:  Inflamm Res       Date:  2013-05-18       Impact factor: 4.575

Review 8.  The Changing Landscape of Renal Inflammation.

Authors:  Thomas Ernandez; Tanya Norton Mayadas
Journal:  Trends Mol Med       Date:  2016-01-07       Impact factor: 11.951

9.  Bone structural effects of variation in the TNFRSF1B gene encoding the tumor necrosis factor receptor 2.

Authors:  B H Mullin; R L Prince; I M Dick; F M A Islam; D J Hart; T D Spector; A Devine; F Dudbridge; S G Wilson
Journal:  Osteoporos Int       Date:  2007-11-24       Impact factor: 4.507

10.  Distinct spatial activation of intrinsic and extrinsic apoptosis pathways in natural scrapie: association with prion-related lesions.

Authors:  Carmen Serrano; Jaber Lyahyai; Rosa Bolea; Luis Varona; Eva Monleón; Juan J Badiola; Pilar Zaragoza; Inmaculada Martín-Burriel
Journal:  Vet Res       Date:  2009-04-30       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.